ÂÜÀòÂÒÂ×

Bradford Navia, MD, PhD, is a highly accomplished medical professional with extensive experience in the pharmaceutical and academic sectors. Currently serving as the Chief Medical Officer at APRINOIA Therapeutics since December 2021, Bradford holds the position of Executive Vice President and global head of R&D. Previously, Bradford was the Executive Director at Sunovion Pharmaceuticals from September 2014 to November 2021 and an Associate Professor at Tufts University Medical School from 1997 to 2013. Bradford obtained a Doctor of Medicine (MD) from the Columbia University Vagelos College of Physicians and Surgeons and a Bachelor of Arts (BA) from Columbia University. Additionally, Bradford earned a Doctor of Philosophy (PhD) in Neuroscience and Genetics from Harvard University.